BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1262253)

  • 1. Antimetabolites produced by microorganisms. XV Synthesis of 2-methyl-L-arginine, 2-methyl-L-ornithine and their enantiomers.
    Maehr H; Yarmchuk L; Leach M
    J Antibiot (Tokyo); 1976 Mar; 29(3):221-6. PubMed ID: 1262253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimetabolites produced by microorganisms XVI. Synthesis of N5-hydroxy-2-methylarginine and N5-hydroxy-2-methylornithine.
    Maehr H; Leach M
    J Antibiot (Tokyo); 1978 Mar; 31(3):165-9. PubMed ID: 649511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 2-methyl and 2-carboxymethyl derivatives of ornithine and arginine.
    Unson CG; Erickson BW
    Int J Pept Protein Res; 1983 Jul; 22(1):50-6. PubMed ID: 6885249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimetabolites produced by microorganisms. XV synthesis of 2-methyl-arginine, 2-methyl-l-ornithine and their enantiomers.
    Maehr H; Yarmchuk L; Kellett M; Palleroni NJ; La Prosser B; Demny TC
    J Antibiot (Tokyo); 1976 Mar; 29(3):213-20. PubMed ID: 816762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic approaches to N(delta)-methylated L-arginine, N(omega)-hydroxy-L-arginine, L-citrulline, and N(delta)-cyano-L-ornithine.
    Schade D; Töpker-Lehmann K; Kotthaus J; Clement B
    J Org Chem; 2008 Feb; 73(3):1025-30. PubMed ID: 18179234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimetabolites produced by microorganisms. IX. Chemical synthesis of N5-hydroxyornithine and N5-hydroxyarginine.
    Maehr H; Leach M
    J Org Chem; 1974 Apr; 39(8):1166-8. PubMed ID: 4847775
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of ornithine and arginine conjugates of cholic acid by mass spectrometry.
    Myher JJ; Marai L; Kuksis A; Yousef IM; Fisher MM
    Can J Biochem; 1975 May; 53(5):583-90. PubMed ID: 1139398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of allose-templated hydroxyornithine and hydroxyarginine analogs.
    Mondal D; Schweizer F
    Carbohydr Res; 2010 Jul; 345(11):1533-40. PubMed ID: 20478556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of optically pure C alpha-methyl-arginine.
    Tian Z; Edwards P; Roeske RW
    Int J Pept Protein Res; 1992 Aug; 40(2):119-26. PubMed ID: 1446969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new non-natural arginine-like amino acid derivative with a sulfamoyl group in the side-chain.
    De Marco R; Di Gioia ML; Leggio A; Liguori A; Perri F; Siciliano C; Viscomi MC
    Amino Acids; 2010 Mar; 38(3):691-700. PubMed ID: 19283444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.
    McCall TB; Feelisch M; Palmer RM; Moncada S
    Br J Pharmacol; 1991 Jan; 102(1):234-8. PubMed ID: 1710525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of conformationally constrained arginine and ornithine analogues based on the 3-substituted pyrrolidine framework.
    Mamai A; Hughes NE; Wurthmann A; Madalengoitia JS
    J Org Chem; 2001 Sep; 66(19):6483-6. PubMed ID: 11559203
    [No Abstract]   [Full Text] [Related]  

  • 13. delta-N-[methyl-14C]Arginine: a simplified preparation.
    Paik WK; Paik MK; Kim S
    Anal Biochem; 1980 May; 104(2):343-6. PubMed ID: 7446960
    [No Abstract]   [Full Text] [Related]  

  • 14. Formation pathways for lysine-arginine cross-links derived from hexoses and pentoses by Maillard processes: unraveling the structure of a pentosidine precursor.
    Biemel KM; Reihl O; Conrad J; Lederer MO
    J Biol Chem; 2001 Jun; 276(26):23405-12. PubMed ID: 11279247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter.
    Bogle RG; Moncada S; Pearson JD; Mann GE
    Br J Pharmacol; 1992 Apr; 105(4):768-70. PubMed ID: 1380372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the L-arginine:nitric oxide pathway in human platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enzymatic route to L-ornithine from L-arginine--activation and stabilization studies on L-arginase.
    Bommarius AS; Makryaleas K; Drauz K
    Biomed Biochim Acta; 1991; 50(10-11):S249-55. PubMed ID: 1820054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptides containing L-arginine analogs: new isozyme-selective inhibitors of nitric oxide synthase.
    Kobayashi N; Higuchi T; Urano Y; Kikuchi K; Hirobe M; Nagano T
    Biol Pharm Bull; 1999 Sep; 22(9):936-40. PubMed ID: 10513616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N5-phosphonoacetyl-L-ornithine (PALO): a convenient synthesis and investigation of influence on regulation of amino acid biosynthetic genes in Saccharomyces cerevisiae.
    Johnson B; Steadman R; Patefield KD; Bunker JJ; Atkin AL; Dussault P
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2351-3. PubMed ID: 21421312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of arginine by nitromalondialdehyde. Synthesis and properties of -(5-nitro-2-pyrimidyl) ornithyl derivatives.
    Signor A; Bonora GM; Biondi L; Nisato D; Marzotto A; Scoffone E
    Biochemistry; 1971 Jul; 10(14):2748-52. PubMed ID: 5558698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.